Evaluating the Efficacy of Artificial Intelligence-based Computer Aided Diagnosis Software That Assists in Determining Whether or Not to Conduct Amyloid PET for the Diagnosis of Alzheimer's Disease by Predicting Amyloid PET Positivity in Mild Cognitive Impairment Patients

NCT05383053 · clinicaltrials.gov ↗
COMPLETED
Status
227
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Neurozen Inc.

Collaborators